TP53 mutations were significantly more frequent in CLCA than in PCAWG-HCC or TCGA-HCC, while CTNNB1 mutations were mutually exclusive with either TP53 or AXIN1 mutations, which is consistent with HCC in European individuals [21]. This evidence concerns the gene AXIN1 and hepatocellular carcinoma.